CONNECT WITH US
HealthTech

HealthTech

Fruits and vegetables outperform medication for treating metabolic acidosis in chronic kidney disease

Medical Xpress logo

Published on

Add as a preferred source on Google
Fruits and vegetables outperform medication for treating metabolic acidosis in chronic kidney disease

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

In people with chronic kidney disease (CKD), oral sodium bicarbonate is a standard treatment for metabolic acidosis (too much acid buildup in the body), but results from a recent clinical trial indicate that dietary acid reduction with base-producing fruits and vegetables may be a better option. The findings will be presented at ASN Kidney Week 2026, Oct. 22–25.

In the trial, 108 adults with stage 3 CKD and metabolic acidosis were randomized to receive fruits and vegetables (to reduce dietary acid by half), oral sodium bicarbonate (also to reduce dietary acid by half) or usual care (36 patients in each group). Participants were followed annually for 10 years.

During follow-up, there were 115 hospitalizations and 166 emergency department visits, and 34 patients needed dialysis. Compared with the usual care group, the fruits and vegetables group had fewer hospitalizations (14 versus 64), fewer emergency department visits (20 versus 88) and less progression to dialysis (four versus 16). There was no difference between those given sodium bicarbonate and those receiving usual care regarding these outcomes.

"Treatment of metabolic acidosis with fruits and vegetables was associated with more favorable long-term clinical outcomes and health care utilization than standard treatment with sodium bicarbonate or usual care, without increasing overall health-system or societal costs," said corresponding author Nimrit Goraya, M.D., of Baylor Scott and White Health.

"These findings support evaluating dietary interventions in chronic kidney disease not only at the individual-patient level but also at the population level, where the cumulative clinical and economic benefits may be substantial.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.